首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   13487篇
  免费   985篇
  国内免费   169篇
耳鼻咽喉   94篇
儿科学   454篇
妇产科学   404篇
基础医学   1799篇
口腔科学   281篇
临床医学   1216篇
内科学   2630篇
皮肤病学   214篇
神经病学   922篇
特种医学   543篇
外科学   2295篇
综合类   637篇
一般理论   4篇
预防医学   742篇
眼科学   349篇
药学   775篇
  1篇
中国医学   78篇
肿瘤学   1203篇
  2023年   135篇
  2022年   184篇
  2021年   344篇
  2020年   237篇
  2019年   309篇
  2018年   335篇
  2017年   269篇
  2016年   300篇
  2015年   354篇
  2014年   450篇
  2013年   551篇
  2012年   860篇
  2011年   920篇
  2010年   558篇
  2009年   479篇
  2008年   728篇
  2007年   713篇
  2006年   714篇
  2005年   709篇
  2004年   671篇
  2003年   595篇
  2002年   557篇
  2001年   528篇
  2000年   414篇
  1999年   361篇
  1998年   140篇
  1997年   140篇
  1996年   107篇
  1995年   106篇
  1994年   78篇
  1993年   69篇
  1992年   166篇
  1991年   157篇
  1990年   166篇
  1989年   171篇
  1988年   145篇
  1987年   146篇
  1986年   120篇
  1985年   97篇
  1984年   63篇
  1983年   45篇
  1982年   26篇
  1981年   41篇
  1980年   34篇
  1979年   58篇
  1978年   37篇
  1977年   39篇
  1976年   34篇
  1975年   29篇
  1973年   26篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
A young woman developed an unusual adenocarcinoma in each submandibular salivary gland at an interval of 30 months. This presentation has not been described previously. The possible etiology for this and treatment options are discussed. The choice of diagnostic imaging (ultrasound versus magnetic resonance imaging) is highlighted. As a result of regular follow-ups using diagnostic ultrasound, a second tumor was observed to reach a dimension of 8 mm in less than 6 months. This is probably the first report documenting the extent of initial growth of this rare tumor.  相似文献   
992.
Low incidence of HPV DNA in sera of pretreatment cervical cancer patients   总被引:11,自引:0,他引:11  
OBJECTIVE: The aim of this study was to investigate the feasibility of using DNA in the circulation as a diagnostic tool for cervical cancer. METHODS: We used PCR followed by Southern hybridization to detect human papillomavirus (HPV) DNA in serum samples taken from patients of cervical cancer before treatment. RESULTS: A total of 60 samples were analyzed. In a set of 40 samples, without knowledge of the HPV DNA status in the corresponding cervical carcinomas, we could detect 8 (20%) positive samples, of which 7 (17.5%) were HPV 16 and 1 (2.5%) was HPV 18. In another set of 20 samples, known to be HPV 16 infected in the corresponding cervical carcinomas, we detected only 4 (20%) HPV-16-positive samples. The occurrence of HPV DNA in sera of cervical cancer patients seems sporadic. CONCLUSION: The low incidence indicates that serum HPV DNA has limited application in the diagnosis of cervical cancer.  相似文献   
993.
PURPOSE: To identify local risk factors for FIGO IB, IIA and IIB bulky cervical squamous cell carcinoma (tumor size > or = 4 cm) patients with node-negative, margin-free tumors treated by radical hysterectomy, pelvic lymph node and para-aortic lymph node dissections without adjuvant therapies. MATERIALS AND METHODS: Thirty-four patients were recruited between 1976 and 1989 because they all declined any postoperative adjuvant therapy. The pathology reports showed that all the specimen margins were free from cancer cells with no para-aortic or pelvic lymph node metastases. The survival interval was calculated starting from the time of surgical intervention to the time of death or the end of this study in the year 2000. RESULT: Tumor variables including cell differentiation, depth of stromal invasion, parametrial invasion, vaginal invasion, uterine body invasion, age, and FIGO stage were analyzed. Only vaginal invasion showed statistical significance for decreasing patient disease-free survival in both univariate and multivariate analyses with p values of 0.003 and 0.002, respectively. CONCLUSION: For node-negative and margin-free patients with bulky cervical squamous cell carcinoma with operable stage IB and IIB, surgical intervention alone could suffice when no vaginal invasion is noted plus an 85% survival rate could be achieved. A prospective pilot study should be initiated although this study showed an excellent survival rate which is perhaps due to the limited number of cases.  相似文献   
994.
995.
OBJECTIVE: To compare the functional performance of subjects with unilateral anterior cruciate ligament (ACL) reconstruction. DESIGN: Cross-sectional comparative clinical trial. SETTING: A physical therapy outpatient department. SUBJECTS: Thirty-one subjects with unilateral ACL reconstruction for more than 5 months. INTERVENTION: Patients under 3 bracing conditions: (1) DonJoy Brace, (2) mechanical placebo brace, or (3) no brace. Running and turning 10 times on a 22-meter figure-8 runway, and running and jumping (and landing) on a semicircular path. MAIN OUTCOME MEASURES: Speed of running and turning, speed of running and jumping, and accuracy of landing after the jump. RESULTS: Subjects performed similarly in conditions 1 and 2 in all the tests, but the speeds of running and turning were significantly slower in conditions 1 and 2 than condition 3 (p =.008--.000). Results of the run and jump tests were not different among all conditions. CONCLUSION: Knee bracing may not improve functional performance of subjects 5 months after ACL reconstruction. The use of such a brace could actually slow down running and turning, irrespective of the mechanical constraints of the brace. These functional outcomes need to be noted when such a brace is used on this group of subjects.  相似文献   
996.
The Safe-Cross wire system, which has optical coherence reflectometry technology for navigating and radiofrequency energy provided at its tip for crossing chronic total occlusions (CTOs), provides a promising means to treat hard, organized CTOs. Using this system, we report on a 60% success rate in patients who had long-standing coronary CTOs that had > or =1 failed attempt using conventional percutaneous coronary intervention.  相似文献   
997.
998.
Recurrent hepatocellular carcinoma (HCC) deserves multidisciplinary treatment in addition to surgical resection. Radiofrequency ablation (RFA) is an evolving, localized, thermal ablative treatment for unresectable hepatocellular carcinoma (HCC). Though the preliminary results of RFA in clinical studies are encouraging, its serious complications should not be underestimated. Portal vein thrombosis as a result of direct blood vessel injury by RFA is rarely reported and is potentially fatal in patients with limited liver reserve due to underlying liver cirrhosis. We present a case of portal vein thrombosis as a complication of RFA treatment for recurrent HCC and illustrate its underlying possible mechanism.  相似文献   
999.
1000.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号